"MEMBS Molecular Biology News" is a bilingual news service from the Middle East Molecul...
“Be part of MEMBS Molecular Biology News Website”
Submit any related scientific, innovation or technology news.
Add any of your organization event to “MEMBS Calendar”.
The more submissions you make, the more “Molcar Points” you earn.
Oct 8, 2018 9:00 am
Oct 6, 2018 10:00 am
Oct 1, 2018 10:00 am
Sep 30, 2018 9:00 am
AstraZeneca and MedImmune, its global biologics research and development arm, today announced top-line results from the GALATHEA Phase III trial for Fasenra (benralizumab) in patients with moderate to very severe chronic obstructive pulmonary dise....